Cutaneous melanomas exhibit a strong positive correlation between CD47 mRNA expression and improved survival, which relates to enhanced NK and CD8 T cell activation in tumors with elevated CD47 [7,8,9]. This evidence concerns the gene CD47 and cutaneous melanoma.